PB
Prosperity Bancshares, Inc.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
72.77
▲ 0.19 (0.26%)
MARKET · —
Price
Open
72.58
Prev close
72.58
Day high
73.19
Day low
72.32
Volume
447.62K
Market cap
$8.75B
P/E (TTM)
12.61
52W range
61.07 – 77.20
Trailing performance
Returnvs SPY
1W
-3.04%
-1.7%
1M
+0.12%
-3.6%
3M
+5.28%
+2.2%
6M
-1.03%
-12.1%
YTD
+5.30%
-7.0%
1Y
+7.47%
-12.5%
3Y
+29.37%
-44.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$8.75B
Enterprise value$9.77B
Revenue (TTM)$1.39B
Gross profit$1.39B
EBITDA—
Net income$562.31M
EPS (TTM)$5.77
Free cash flow—
Total cash$1.68B
Total debt$2.71B
Book value / share$82.52
Shares outstanding120.18M
Float109.48M
Short % of float4.23%
Dividend yield3.30%
Beta (5Y)0.65
Valuation & profitability ratios
Trailing P/E12.61
Forward P/E9.94
PEG ratio4.18
Price / sales—
Price / book0.88
EV / revenue7.02
EV / EBITDA—
Gross margin0.00%
Operating margin58.04%
Profit margin40.42%
Return on equity7.07%
Return on assets1.37%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.25B | $1.20B | $1.11B | $1.15B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $542.84M | $479.39M | $419.32M | $524.52M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $542.84M | $479.39M | $419.32M | $524.52M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.55 | 1.62 | +4.5% |
| Mar 2026 | 1.45 | 1.50 | +3.2% |
| Dec 2025 | 1.45 | 1.46 | +0.9% |
| Sep 2025 | 1.44 | 1.45 | +0.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.61 | 14 | $491.69M | +55.9% |
| Next quarter | 1.69 | 14 | $501.33M | +57.5% |
| Current year | 6.40 | 14 | $1.75B | +39.4% |
| Next year | 7.32 | 14 | $2.05B | +17.5% |
Analyst targets & ownership
Mean target$81.38
High target$90.00
Low target$68.00
Implied upside11.84%
Analyst count13
ConsensusBUY
Strong buy / Buy1 / 4
Hold9
Sell / Strong sell0 / 1
Held by insiders3.55%
Held by institutions75.46%
Institutions holding563
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+307.34K
Net buying
Buy transactions
16
337.44K shares
Sell transactions
27
30.10K shares
Net transactions
+43
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
4.26M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | HOLMES NED S Director |
SELL | 1.10K | $81.03K | |
| Aug 12, 26 | HOLMES NED S Director |
SELL | 1.10K | $81.55K | |
| Aug 5, 26 | HOLMES NED S Director |
SELL | 1.10K | $82.07K | |
| Jul 29, 26 | HOLMES NED S Director |
SELL | 1.10K | $81.69K | |
| Jul 22, 26 | HOLMES NED S Director |
SELL | 1.10K | $80.28K | |
| Jul 15, 26 | HOLMES NED S Director |
SELL | 1.10K | $80.36K | |
| Jul 8, 26 | HOLMES NED S Director |
SELL | 1.10K | $77.64K | |
| Jul 6, 26 | FRANKLIN ROBERT R JR Officer and Director |
STOCK | 25.00K | $0 | Direct |
| Jul 1, 26 | HOLMES NED S Director |
SELL | 1.10K | $80.90K | |
| Jul 1, 26 | SWINBANK JOE B Director |
STOCK | 126.76K | $0 | |
| Jul 1, 26 | RASCHE CHARLOTTE M General Counsel |
STOCK | 950 | $0 | Direct |
| Jul 1, 26 | LUEDKE WILLIAM T. IV Director |
STOCK | 5.34K | $0 | Direct |
| Jul 1, 26 | FRANKLIN ROBERT R JR Officer and Director |
STOCK | 132.39K | $0 | Direct |
| Jun 24, 26 | HOLMES NED S Director |
SELL | 1.10K | $80.00K |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOULIGNY JAMES A |
Director | 342.04K | Stock Award(Grant) |
FRANKLIN ROBERT R JR |
Officer and Director | 157.39K | Stock Award(Grant) |
HANIGAN KEVIN J |
President | 282.16K | Stock Award(Grant) |
HESTER RANDY D |
Officer | 233.70K | Stock Award(Grant) |
HOLMES NED S |
Director | — | Sale |
MUELLER PERRYJR |
Director | 269.84K | Stock Award(Grant) |
SAFADY EDWARD Z |
Officer | 181.52K | Stock Award(Grant) |
STAFFORD HARRISONII |
Director | 298.94K | Stock Award(Grant) |
TIMANUS H E JR |
Chairman of the Board | 532.76K | Stock Award(Grant) |
ZALMAN DAVID |
Chief Executive Officer | 898.02K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
73.82
-1.42% from price
SMA 20
74.05
-1.73% from price
SMA 50
73.06
-0.39% from price
SMA 100
70.93
+2.59% from price
SMA 200
70.35
+3.44% from price
EMA 12
73.68
-1.23% from price
EMA 26
73.57
-1.09% from price
EMA 50
72.84
-0.09% from price
RSI (14)
44.3
Neutral
MACD (12,26,9)
0.11
Hist -0.28
ATR (14)
1.14
1.57% of price
Realised vol 30D
15.0%
Annualised
Bollinger upper
75.71
20, 2σ
Bollinger lower
72.38
20, 2σ
50 / 200 cross
Golden
73.06 vs 70.35
Trend bias
Above 200
+3.44%
Risk profile
Beta vs SPY
0.48
Less volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
15.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-15.7%
Peak to trough
Max drawdown 5Y
-37.0%
Peak to trough
ATR 14
1.14
1.57% of price
Beta (reported)
0.65
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.46
Put-heavy session
Put / call open interest
0.19
Positioning, not flow
Max pain
65.00
-10.7% from spot
ATM implied vol
21.3%
Nearest strike to spot
Skew (10% OTM)
+24.0%
Puts bid over calls
Call volume
37
Contracts, this expiry
Put volume
54
Contracts, this expiry
Heaviest call OI
75.00
340 contracts
Heaviest put OI
65.00
57 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
PB vs. CFR: Which Stock Is the Better Value Option?
Zacks · 1d ago
Prosperity Bancshares (PB) is a Top Dividend Stock Right Now: Should You Buy?
Zacks · 5d ago
3 Bank Stocks We Find Risky
StockStory · 7d ago
Regional Banks Stocks Q2 Results: Benchmarking Prosperity Bancshares (NYSE:PB)
StockStory · 10d ago
Prosperity Bancshares (PB) Q2 2026 Earnings Call
Motley Fool · 15d ago
Prosperity Bancshares (PB) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 17d ago
PB vs. CFR: Which Stock Should Value Investors Buy Now?
Zacks · 17d ago
PB Q2 Deep Dive: M&A Integration and Margin Expansion Shape Outlook
StockStory · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.